David J Mazzo
CIK 1334549 · President & CEO · last filed 2026-01-13
David J Mazzo is a President & CEO who has filed 68 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for LSTA, was dated Jan 13, 2026. Across all open-market trades the lifetime net is +$27.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.75M
9
68
$27.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LSTA | President & CEO | 319,744 | $3.56 | $1.14M | $0 | 8 | 2026-01-13 |
| LISATA THERAPEUTICS, INC. (CLBS) Delisted | Chief Executive Officer | 739,444 | $6.40 | $4.73M | $27.9K | 22 | 2022-09-02 |
| PALISADE BIO, INC. (SNCA) Delisted | Director | — | $9.96 | — | $0 | 2 | 2021-04-26 |
| EYPT | Director | 200,083 | $13.03 | $2.61M | $0 | 10 | 2020-03-03 |
| PALISADE BIO, INC. (CUR) Delisted | Director | — | — | — | $0 | 2 | 2019-10-11 |
| EyePoint, Inc. (PSDV) Delisted | Director | — | — | — | $0 | 11 | 2017-12-19 |
| LISATA THERAPEUTICS, INC. (NBS) Delisted | Chief Executive Officer | 239,543 | — | — | $0 | 3 | 2015-06-04 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 336,394 | — | — | $0 | 8 | 2014-02-14 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | Chief Executive Officer | — | — | — | $0 | 2 | 2014-01-03 |
Recent Filings
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-13 | LSTA | Mixed | +39,904 | -$81.0K | EDGAR |
| 2025-01-13 | LSTA | Mixed | +50,538 | -$115.5K | EDGAR |
| 2024-10-02 | LSTA | Mixed | +31,036 | $90.9K | EDGAR |
| 2024-01-12 | LSTA | Tax (F) | −1,026 | -$3.1K | EDGAR |
| 2024-01-11 | LSTA | Mixed | +70,484 | -$72.2K | EDGAR |
| 2023-01-17 | LSTA | Tax (F) | −397 | -$1.4K | EDGAR |
| 2023-01-12 | LSTA | Tax (F) | −1,030 | -$3.3K | EDGAR |
| 2023-01-11 | LSTA | Mixed | +48,685 | -$34.6K | EDGAR |
| 2022-09-02 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Mixed | +80,258 | $40.1K | EDGAR |
| 2022-01-18 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Tax (F) | −13,082 | -$10.6K | EDGAR |